Gastric Cancer Drugs Market - By Type (Imatnib, Trastuzumab), By End-User (Hospitals, Clinics Cancer Specialty Centers), By Route of Administration (Oral, Parental) And By Region, Opportunities And Strategies – Global Forecast To 2030

Request Free Sample Buy Report

Gastric Cancer Drugs Market 2021 - By Type (Imatnib, Trastuzumab), By End-User (Hospitals, Clinics Cancer Specialty Centers), By Route Of Administration (Oral, Parental) And By Region, Opportunities And Strategies – Global Forecast To 2030

Starting Price : $5000.00 | Pages : 282 | Published : August 2021 | | Format : pdf

Purchase Options

Request Sample

Request For Discount

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

Gastric Cancer Drugs Market Definition

The gastric cancer drugs market consists of sales of gastric cancer drugs and related services by entities (organizations, sole traders and partnerships) that produce gastric cancer drugs to prevent, diagnose and treat gastric cancer. This industry includes establishments that produce drugs used in chemotherapy, surgery and radio therapies for treating gastric cancer.

Gastric cancer, also known as stomach cancer, is a disease in which malignant (cancer) cells are formed on the lining of stomach resulting in stomach pain and indigestion.

The pharmaceutical industry develops drugs to diagnose, treat or prevent diseases. Pharmaceutical drugs are subjected to various laws and regulations that deal with patenting, testing, safety, efficacy and marketing. Gastric cancer drugs manufacturers produce pharmaceutical drugs made from active pharmaceutical ingredients (API) and excipients.

Gastric Cancer Drugs Market Size

The global gastric cancer drugs market reached a value of nearly $2,516.2 million in 2020, having decreased at a compound annual growth rate (CAGR) of -13.6% since 2015. The market is expected to grow from $2,516.2 million in 2020 to $3,914.8 million in 2025 at a rate of 9.2%. The gastric cancer drugs market is then expected to grow at a CAGR of 4.3% from 2025 and reach $4,832.0 million in 2030.

Growth in the historic period in the gastric cancer drugs market resulted from increase in pharmaceutical R&D expenditure, increased healthcare expenditure, strong economic growth in emerging markets and rapid growth in elderly population. The market was restrained by patent expiration of drugs, pricing pressures from regulators, low healthcare access and challenges due to regulatory changes.

Going forward Increase in gastric cancer incidence rate, strong pipeline of drugs, rise in acquisitions and partnerships for drug development, rise in healthcare expenditure high potential in emerging economies, increasing geriatric population and revised FDA regulations to facilitate biologics drug development will drive the growth in the gastric cancer drugs market. Factors that could hinder the growth of the market in the future include high costs of drugs, the coronavirus pandemic and adverse effects of gastric cancer drugs.

Gastric Cancer Drugs Market Drivers

The key drivers of the gastric cancer drugs market included:

Increase in Gastric Cancer Incidence Rate

The rise in the number of gastric cancer cases across the globe is likely to contribute to the growth of the gastric cancer drugs market during the forecast period. According to the estimates stomach cancer is the fifth most commonly diagnosed cancer globally and approximately 27,600 new cases of stomach cancer will be diagnosed in the US in 2020. According to the American Cancer Society, it is estimated that there will be 26,560 new cases of stomach cancer and 11,180 deaths from gastric cancer in the United States in 2021. Therefore, the rise in gastric cancer incidence rate globally is anticipated to boost the demand for gastric cancer drugs over the forthcoming years.

Gastric Cancer Drugs Market Restraints

The key restraints on the gastric cancer drugs market include:

High Costs Of Drugs

High costs associated with gastric cancer treatment is a major issue faced by many countries. The pressure to contain costs and demonstrate value is widespread. Political uncertainty and persistent economic stress in numerous countries are calling into question the sustainability of public health care funding. As a result, in less wealthy countries such as Chad and Serbia, pharmaceutical companies are facing the pressure of reducing the price of drugs. The higher costs associated with drugs and treatment of gastric carcinomas are showing a direct effect on the revenues of gastric cancer drug manufacturers. Similarly, a huge amount is involved in new cancer drug development with a high risk of failure is expected to limit the growth of the gastric cancer drugs market. Drug development involves lot of investment and expenditure, yet the chance of success is minimal. Therefore, prolonged process of development with a high risk of failure also acts as a restraining factor for the gastric cancer drugs market’s growth.

Gastric Cancer Drugs Market Trends

Major trends shaping the gastric cancer drugs market include the following –

Strategic Collaborations And Agreements

Many companies in the gastric cancer drugs market are strategically partnering and collaborating with other companies to broaden their product portfolios and expand their gastric cancer drugs business. These collaborations are helping drug manufacturing companies to enhance their product strength in specific therapy areas. For instance, Basilea Pharmaceutica entered into a clinical trial collaboration and supply agreement with Eli Lilly and Company for the use of the anti-VEGFR2 antibody ramucirumab (CYRAMZA®) 1 in the ongoing multi-cohort phase 1/2 study FIDES-03 with the FGFR inhibitor derazantinib in advanced gastric (stomach) cancer patients with FGFR genetic aberrations.

Global Research Initiatives And Funding

Pharmaceutical companies and federal governments are increasingly working together in partnerships and collaborations to provide funding and implement incentive programs for the research and development (R&D) of gastric cancer drugs. These partnerships provide financial and technical assistance across different clinical development phases to pharmaceutical companies. For example, No Stomach For Cancer funds research that is essential in leading to a cure for stomach cancer and offers funding to support promising stomach cancer research projects worldwide.

Opportunities And Recommendations In Gastric Cancer Drugs Market

Opportunities –The top opportunities in the gastric cancer drugs market segmented by type of gastric cancer drugs will arise in the trastuszumab gastric cancer drugs segment, which will gain $692 million of global annual sales by 2025. The top opportunities in the gastric cancer drugs market segmented by end user will arise in the hospitals segment, which will gain $623 million of global annual sales by 2025. The top opportunities in the gastric cancer drugs market segmented by route of administration will arise in the parenteral segment, which will gain $989.0 million of global annual sales by 2025. The gastric cancer drugs market size will gain the most in USA at $562 million.

Recommendations-To take advantage of these opportunities, The Business Research Company recommends the gastric cancer drugs companies to focus on adopting artificial intelligence technologies, use of CRISPR-Cas9 technology, strategic alliance for research & development, offer bundled payments, expand in emerging markets to gain market share, focus on mergers and acquisitions, use direct-to-marketing approach to maximize reach, utilize big data analytics to improve marketing activities, and target the geriatric population.

Gastric Cancer Drugs Market Segmentation

The gastric cancer drugs market is segmented by type, by end-user and by route of administration.
By Type -
The gastric cancer drugs market is segmented by type into

a) Imatnib
b) Trastuzumab
c) Others

The trastuzumab gastric cancer drugs market was the largest segment of the gastric cancer drugs market segmented by type, accounting for 50.0% of the total in 2020. Going forward, the others segment is expected to be the fastest growing segment in the gastric cancer drugs market segmented by type, at a CAGR of 8.3% during 2020-2025.
By End-User –
The gastric cancer drugs market is segmented by end-user into

a) Hospitals
b) Clinics
c) Cancer Specialty Centers

The hospitals market was the largest segment of the gastric cancer drugs market segmented by end-user, accounting for 44.7% of the total in 2020. Going forward, the cancer specialty centers segment is expected to be the fastest growing segment in the gastric cancer drugs market segmented by end-user, at a CAGR of 4.6% during 2020-2025.
By Route of Administration –
The gastric cancer drug market is segmented by route of administration into

a) Oral
b) Parental

The parenteral market was the largest segment of the gastric cancer drugs market segmented by route of administration, accounting for 57% of the total in 2020. Going forward, it is expected to be the fastest growing segment in the gastric cancer drugs market segmented by route of administration, at a CAGR of 6.0% during 2020-2025.
By Geography -
The gastric cancer drugs market is segment by geography into

• China
• India
• Japan
• Australia
• Indonesia
• South Korea

• USA

• Brazil

• France
• Germany
• UK

• Russia

North America was the largest region in the global gastric cancer drugs market, accounting for 35.0% of the total in 2020. It was followed by the Asia Pacific and Western Europe and then the other regions. Going forward, the fastest-growing regions in the gastric cancer drugs market will be North America and, Africa where growth will be at CAGRs of 5.7% and 4.4% respectively. These will be followed by Middle East and Asia Pacific, where the markets are expected to register CAGRs of 3.9% and 3.9% respectively.

Gastric Cancer Drugs Competitive Landscape

Major Competitors In The Gastric Cancer Drugs Market Are:

F. Hoffmann-La Roche

Eli Lilly and Company

Otsuka Pharmaceutical

Jiangsu HengRui Medicine

Biocon

Other Competitors In The Gastric Cancer Drugs Market Include:

Abbott Laboratories

Apikos Pharma

AQVIDA GmbH

Arlak Biotech

Ascedis Health

Astellas Pharma Inc

AstraZeneca plc

Baxter International Inc.

BeiGene

Biocad

BMS

Bristol-Myers Squibb

CARsgen Therapeutics

Celltrion Inc

Celnova Pharma

Celon Pharma

CStone Pharma

Daiichi Pharmaceutical

Eurofarma Laboratórios S.A.

Gilead Sciences

GlaxoSmithKline PLC

Gulf Pharmaceutical Industries

Healthkind labs Pvt. Ltd.

Imugene Limited

Johnson & Johnson

JW Therapeutics

Kolaz biotech

Merck & Co. Inc.

Mylan Laboratories

Novartis AG

Pfizer Inc.

Pierre Fabre Group

PV Pharma Healthcare

Sankyo

Sanofi

Saudi Pharmaceutical Industries and Medical Appliances Corporation

SwisscheM Healthcare Pvt.Ltd

Takeda Pharmaceuticals

Teva Pharmaceutical Industries Ltd

TUTEUR Argentina

Veropharm

Table Of Contents

1. Gastric Cancer Drugs Market Executive Summary

2. Table of Contents

3. List of Figures

4. List of Tables

5. Report Structure

6. Introduction

6.1.1.Segmentation By Geography

6.1.2. Segmentation By Type

6.1.3.Segmentation By End-User

6.1.4. Segmentation By Route Of Administration

7. Gastric Cancer Drugs Market Characteristics

7.1. Market Definition

7.2. Market Segmentation By Type

7.2.1. Imatinib

7.2.2.Trastuzumab

7.2.3. Others

7.3. Market Segmentation By End-User

7.3.1. Hospital

7.3.2. Clinics

7.3.3. Speciality Cancer Centers

7.4. Market Segmentation By Route Of Administration

7.4.1. Oral

7.4.2.Parenteral

8. Gastric Cancer Drugs Market Trends And Strategies

8.1. Strategic Collaborations And Agreements

8.2. Global Research Initiatives And Funding

8.3. Increasing Number Of Pipeline Studies And Drug Development

8.4. Investment In Artificial Intelligence

8.5. Development And Increasing Demand For Next Generation Biologics

8.6. CRISPR-Cas9 Technology Use In Gastric Cancer Treatment

8.7. Use Of 3D Printing To Test New Drugs

9. COVID-19 Impact On The Gastric Cancer Drugs Market

9.1. Clinical Trial Delays

9.2. Low Usage Of Drugs

9.3. Supply Chain Issues

9.4. Shortage In Resources

10. Global Gastric Cancer Drugs Market Size And Growth

10.1. Market Size

10.2. Historic Market Growth, 2015 – 2020, Value ($ Million)

10.2.1. Drivers Of The Market 2015 – 2020

10.2.2. Restraints On The Market 2015 – 2020

10.3. Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

10.3.1. Drivers Of The Market 2020 – 2025

10.3.2. Restraints On The Market 2020 – 2025

11. Global Gastric Cancer Drugs Market Segmentation

11.1.Global Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

11.1.1. Trastuzumab

11.1.2. Others

11.1.3. Imatinib

11.2. Global Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

11.2.1. Hospitals

11.2.2. Cancer Specialty Centers

11.2.3. Clinics

12. Gastric Cancer Drugs Market, Regional And Country Analysis

12.1. Global Gastric Cancer Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

12.2. Global Gastric Cancer Drugs Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

12.3. Global Gastric Cancer Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

12.3.1. Parenteral

12.3.2. Oral

13. Asia-Pacific Gastric Cancer Drugs Market

13.1.Asia-Pacific Gastric Cancer Drugs Market Overview

13.1.1. Region Information

13.1.2. Market Information

13.1.3. COVID-19 Impact

13.1.4. Background Information

13.1.5. Government Initiatives

13.1.6. Regulations

13.1.7. Regulatory Bodies

13.1.8. Major Associations

13.1.9. Taxes Levied

13.1.10. Corporate Tax Structure

13.1.11. Investments

13.1.12. Major Companies

13.2. Asia-Pacific Gastric Cancer Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

13.3.Asia-Pacific Gastric Cancer Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

13.4. Asia-Pacific Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

13.5.Asia-Pacific Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

13.6. Asia-Pacific Gastric Cancer Drugs Market: Country Analysis

13.7. China Gastric Cancer Drugs Market

13.8. China Gastric Cancer Drugs Market Overview

13.8.1. Country Information

13.8.2. Market Information

13.8.3. COVID-19 Impact

13.8.4. Background information

13.8.5. Government Initiatives

13.8.6. Regulations

13.8.7. Regulatory Bodies

13.8.8. Major Associations

13.8.9. Taxes levied

13.8.10. Corporate tax structure

13.8.11. Investments

13.8.12. Major Companies

13.9. China Gastric Cancer Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

13.10. China Gastric Cancer Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

13.11. China Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

13.12. China Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

13.13. India Gastric Cancer Drugs Market

13.14. India Gastric Cancer Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

13.15. India Gastric Cancer Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

13.16. India Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

13.17. India Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

13.18. Japan Gastric Cancer Drugs Market

13.19. Japan Gastric Cancer Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

13.20. Japan Gastric Cancer Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

13.21. Japan Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

13.22. Japan Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

13.23. Australia Gastric Cancer Drugs Market

13.24. Australia Gastric Cancer Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

13.25. Australia Gastric Cancer Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

13.26. Australia Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

13.27. Australia Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

13.28. Indonesia Gastric Cancer Drugs Market

13.29. Indonesia Gastric Cancer Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

13.30. Indonesia Gastric Cancer Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

13.31. Indonesia Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

13.32. Indonesia Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

13.33. South Korea Gastric Cancer Drugs Market

13.34. South Korea Gastric Cancer Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

13.35. South Korea Gastric Cancer Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

13.36. South Korea Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

13.37. South Korea Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

14. Western Europe Gastric Cancer Drugs Market

14.1. Western Europe Gastric Cancer Drugs Market Overview

14.1.1. Region Information

14.1.2. Market Information

14.1.3. COVID-19 Impact

14.1.4. Background Information

14.1.5. New Drug Approvals

14.1.6. Government Initiatives

14.1.7. Regulations

14.1.8. Regulatory Bodies

14.1.9. Major Associations

14.1.10. Taxes Levied

14.1.11. Corporate Tax Structure

14.1.12. Investment

14.1.13. Major Companies

14.2. Western Europe Gastric Cancer Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

14.3. Western Europe Gastric Cancer Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

14.4. Western Europe Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

14.5. Western Europe Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

14.6. Western Europe Gastric Cancer Drugs Market: Country Analysis

14.7.UK Gastric Cancer Drugs Market

14.8. UK Gastric Cancer Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

14.9. UK Gastric Cancer Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

14.10. UK Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

14.11. UK Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

14.12. Germany Gastric Cancer Drugs Market

14.13. Germany Gastric Cancer Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

14.14. Germany Gastric Cancer Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

14.15. Germany Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

14.16. Germany Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

14.17. France Gastric Cancer Drugs Market

14.18. France Gastric Cancer Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

14.19. France Gastric Cancer Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

14.20. France Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

14.21. France Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

15. Eastern Europe Gastric Cancer Drugs Market

15.1.Eastern Europe Gastric Cancer Drugs Market Overview

15.1.1. Region Information

15.1.2. Market Information

15.1.3. COVID-19 Impact

15.1.4. Background Information

15.1.5. New Drug Approvals

15.1.6. Government Initiatives

15.1.7. Regulations

15.1.8. Regulatory Bodies

15.1.9. Major Associations

15.1.10. Taxes Levied

15.1.11. Corporate Tax Structure

15.1.12. Investments

15.1.13. Major Companies

15.2. Eastern Europe Gastric Cancer Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

15.3.Eastern Europe Gastric Cancer Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

15.4. Eastern Europe Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

15.5.Eastern Europe Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

15.6. Eastern Europe Gastric Cancer Drugs Market: Country Analysis

15.7. Russia Gastric Cancer Drugs Market

15.8. Russia Gastric Cancer Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

15.9. Russia Gastric Cancer Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

15.10. Russia Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

15.11. Russia Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

16. North America Gastric Cancer Drugs Market

16.1. North America Gastric Cancer Drugs Market Overview

16.1.1. Region Information

16.1.2. Market Information

16.1.3. COVID-19 Impact

16.1.4. Background Information

16.1.5. New Drug Approvals

16.1.6. Government Initiatives

16.1.7. Regulations

16.1.8. Regulatory Bodies

16.1.9. Major Associations

16.1.10. Taxes levied

16.1.11. Corporate Tax Structure

16.1.12. Investments

16.1.13. Major Companies

16.2. North America Gastric Cancer Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

16.3. North America Gastric Cancer Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

16.4. North America Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

16.5. North America Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

16.6. North America Gastric Cancer Drugs Market: Country Analysis

16.7.USA Gastric Cancer Drugs Market

16.8. USA Gastric Cancer Drugs Market Overview

16.8.1. Region Information

16.8.2. Market Information

16.8.3. COVID-19 Impact

16.8.4. Background Information

16.8.5. New Drug Approvals

16.8.6. Government Initiatives

16.8.7. Regulations

16.8.8. Regulatory Bodies

16.8.9. Major Associations

16.8.10. Taxes levied

16.8.11. Corporate Tax Structure

16.8.12. Investment

16.8.13. Major Companies

16.9. USA Gastric Cancer Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

16.10. USA Gastric Cancer Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

16.11. USA Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

16.12. USA Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

17. South America Gastric Cancer Drugs Market

17.1. South America Gastric Cancer Drugs Market Overview

17.1.1. Region Information

17.1.2. COVID-19 Impact

17.1.3. Market Information

17.1.4. Background Information

17.1.5. New Drug Approvals

17.1.6. Government Initiatives

17.1.7. Regulations

17.1.8. Regulatory Bodies

17.1.9. Major Associations

17.1.10. Taxes Levied

17.1.11. Corporate Tax Structure

17.1.12. Investments

17.1.13. Major Companies

17.2.South America Gastric Cancer Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

17.3. South America Gastric Cancer Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

17.4.South America Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

17.5. South America Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

17.6.South America Gastric Cancer Drugs Market: Country Analysis

17.7. Brazil Gastric Cancer Drugs Market

17.8.Brazil Gastric Cancer Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

17.9.Brazil Gastric Cancer Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

17.10. Brazil Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

17.11. Brazil Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

18. Middle East Gastric Cancer Drugs Market

18.1. Middle East Gastric Cancer Drugs Market Overview

18.1.1. Region Information

18.1.2. Market Information

18.1.3. COVID-19 Impact

18.1.4. Background Information

18.1.5. Government Initiatives

18.1.6. Regulations

18.1.7. Regulatory Bodies

18.1.8. Major Associations

18.1.9. Taxes levied

18.1.10. Corporate Tax Structure

18.1.11. Investment

18.1.12. Major Companies

18.2. Middle East Gastric Cancer Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

18.3. Middle East Gastric Cancer Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

18.4. Middle East Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

18.5. Middle East Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

19. Africa Gastric Cancer Drugs Market

19.1. Africa Gastric Cancer Drugs Market Overview

19.1.1. Region Information

19.1.2. Market Information

19.1.3. COVID-19 Impact

19.1.4. Background Information

19.1.5. Government Initiatives

19.1.6. Regulations

19.1.7. Regulatory Bodies

19.1.8. Major Associations

19.1.9. Taxes levied

19.1.10. Corporate Tax Structure

19.1.11. Investment

19.1.12. Major Companies

19.2. Africa Gastric Cancer Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

19.3. Africa Gastric Cancer Drugs Market, Forecast Market Growth, 2020 – 2025, 2030FValue ($ Million)

19.4. Africa Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

19.5. Africa Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

20. Global Gastric Cancer Drugs Market Competitive Landscape

20.1. Company Profiles

20.2. F. Hoffmann-La Roche Ltd

20.2.1. Company Overview

20.2.2. Products And Services

20.2.3. Financial Overview

20.3. Eli Lilly And Company

20.3.1. Company Overview

20.3.2. Products And Services

20.3.3. Business Strategy

20.3.4. Financial Overview

20.4. Otsuka Pharmaceutical

20.4.1. Company Overview

20.4.2. Products And Services

20.4.3. Business Strategy

20.4.4. Financial Overview

20.5. Jiangsu HengRui Medicine

20.5.1. Company Overview

20.5.2. Products And Services

20.5.3. Business Strategy

20.5.4. Financial Overview

20.6. Biocon

20.6.1. Company Overview

20.6.2. Products And Services

20.6.3. Business Strategy

20.6.4. Financial Overview

21. Gastric Cancer Drugs Pipeline Analysis

22. Key Mergers And Acquisitions In The Gastric Cancer Drugs Market

22.1. Compass Therapeutics, Inc. Acquired TRIGR Therapeutics, Inc.

22.2. Agilent Technologies Acquired Resolution Bioscience

22.3. Amgen Inc. Acquired Five Prime Technologies

22.4. Takeda Pharmaceutical Co. Acquired Maverick Therapeutics

22.5. Pfizer Acquired Array Biopharma

22.6. Eli Lilly Acquired Loxo Oncology

23. Gastric Cancer Drugs Market Opportunities And Strategies

23.1. Global Gastric Cancer Drugs Market In 2025 – Countries Offering Most New Opportunities

23.2. Global Gastric Cancer Drugs Market In 2025 – Segments Offering Most New Opportunities

23.3. Global Gastric Cancer Drugs Market In 2025 – Growth Strategies

23.3.1. Market Trend Based Strategies

23.3.2. Competitor Strategies

24. Gastric Cancer Drugs Market, Conclusions And Recommendations

24.1. Conclusions

24.2. Recommendations

24.2.1. Product

24.2.2. Price

24.2.3. Place

24.2.4. Promotion

24.2.5. People

25. Appendix

25.1. Market Data Sources

25.2. Research Methodology

25.3. Currencies

25.4. Research Inquiries

25.5. The Business Research Company

25.6. Copyright and Disclaimer

List Of Tables

Table 1: Global Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million

Table 2: Global Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 3: Global Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 4: Global Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 5: Global Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 6: Global Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 7: Global Gastric Cancer Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %

Table 8: Global Gastric Cancer Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 9: Global Gastric Cancer Drugs Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %

Table 10: Global Gastric Cancer Drugs Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 11: Global Gastric Cancer Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 12: Global Gastric Cancer Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 13: Asia Pacific GDP Per Capita, 2015-2020, $

Table 14: Asia Pacific, Population By Age Group, By Country, 2015-2023, Thousands

Table 15: Asia-Pacific Public Healthcare Expenditure, 2015-2019, $ Billion

Table 16: Asia-Pacific Private Healthcare Expenditure, 2015-2019, $ Billion

Table 17: Asia-Pacific Healthcare Services Market Size, 2015-2020, $ Billion

Table 18: Asia-Pacific Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million

Table 19: Asia-Pacific Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 20: Asia-Pacific Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 21: Asia-Pacific Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 22: Asia-Pacific Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 23: Asia-Pacific Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 24: China GDP Per Capita, 2015-2020, $

Table 25: China, Population By Age Group, 2015-2023, Thousands

Table 26: China Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2019, $ Billion

Table 27: China Healthcare Services Market Size, 2015-2020, $ Billion

Table 28: China Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million

Table 29: China Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 30: China Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 31: China Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 32: China Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 33: China Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 34: India Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million

Table 35: India Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 36: India Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 37: India Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 38: India Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 39: India Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 40: Japan Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million

Table 41: Japan Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 42: Japan Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 43: Japan Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 44: Japan Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 45: Japan Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 46: Australia Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million

Table 47: Australia Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 48: Australia Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 49: Australia Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 50: Australia Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 51: Australia Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 52: Indonesia Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million

Table 53: Indonesia Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 54: Indonesia Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 55: Indonesia Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 56: Indonesia Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 57: Indonesia Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 58: South Korea Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million

Table 59: South Korea Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 60: South Korea Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 61: South Korea Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 62: South Korea Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 63: South Korea Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 64: Western Europe GDP Per Capita, 2015-2020, $

Table 65: Western Europe, Population By Age Group, By Country, 2015-2023, Thousands

Table 66: Western Europe Public Healthcare Expenditure, 2015-2019, $ Billion

Table 67: Western Europe Private Healthcare Expenditure, 2015-2019, $ Billion

Table 68: Western Europe Healthcare Services Market Size, 2015-2020, $ Billion

Table 69: Western Europe Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million

Table 70: Western Europe Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 71: Western Europe Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 72: Western Europe Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 73: Western Europe Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 74: Western Europe Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 75: UK Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million

Table 76: UK Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 77: UK Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 78: UK Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 79: UK Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 80: UK Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 81: Germany Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million

Table 82: Germany Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 83: Germany Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 84: Germany Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 85: Germany Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 86: Germany Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 87: France Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million

Table 88: France Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 89: France Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 90: France Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 91: France Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 92: France Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 93: Eastern Europe GDP Per Capita, 2015-2020, $

Table 94: Eastern Europe, Population By Age Group, By Country, 2015-2023, Thousands

Table 95: Eastern Europe Public Healthcare Expenditure, 2015-2019, $ Billion

Table 96: Eastern Europe Private Healthcare Expenditure, 2015-2019, $ Billion

Table 97: Eastern Europe Healthcare Services Market Size, 2015-2020, $ Billion

Table 98: Eastern Europe Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million

Table 99: Eastern Europe Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 100: Eastern Europe Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 101: Eastern Europe Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 102: Eastern Europe Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 103: Eastern Europe Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 104: Russia Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million

Table 105: Russia Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 106: Russia Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 107: Russia Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 108: Russia Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 109: Russia Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 110: North America GDP Per Capita, 2015-2020, $

Table 111: North America, Population By Age Group, By Country, 2015-2023, Thousands

Table 112: North America Public Healthcare Expenditure, 2015-2019, $ Billion

Table 113: North America Private Healthcare Expenditure, 2013-2017, $ Billion

Table 114: North America Healthcare Services Market Size, 2015-2020, $ Billion

Table 115: North America Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million

Table 116: North America Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 117: North America Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 118: North America Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 119: North America Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 120: North America Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 121: USA GDP Per Capita, 2015-2020, $

Table 122: USA, Population By Age Group, 2015-2023, Thousands

Table 123: USA Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2019, $ Billion

Table 124: USA Healthcare Services Market Size, 2015-2020, $ Billion

Table 125: USA Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million

Table 126: USA Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 127: USA Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 128: USA Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 129: USA Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 130: USA Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 131: South America GDP Per Capita, 2015-2020, $

Table 132: South America, Population By Age Group, By Country, 2015-2023, Thousands

Table 133: South America Public Healthcare Expenditure, 2015-2019, $ Billion

Table 134: South America Private Healthcare Expenditure, 2015-2019, $ Billion

Table 135: South America Healthcare Services Market Size, 2015-2020, $ Billion

Table 136: South America Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million

Table 137: South America Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 138: South America Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 139: South America Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 140: South America Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 141: South America Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 142: Brazil Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million

Table 143: Brazil Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 144: Brazil Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 145: Brazil Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 146: Brazil Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 147: Brazil Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 148: Middle East GDP Per Capita, 2015-2020, $

Table 149: Middle East, Population By Age Group, By Country, 2015-2023, Thousands

Table 150: Middle East Public Healthcare Expenditure, 2015-2019, $ Billion

Table 151: Middle East Private Healthcare Expenditure, 2015-2019, $ Billion

Table 152: Middle East Healthcare Services Market Size, 2015-2020, $ Billion

Table 153: Middle East Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million

Table 154: Middle East Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 155: Middle East Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 156: Middle East Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 157: Middle East Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 158: Middle East Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 159: Africa GDP Per Capita, 2015-2020, $

Table 160: Africa, Population By Age Group, By Country, 2015-2023, Thousands

Table 161: Africa Public Healthcare Expenditure, 2015-2019, $ Billion

Table 162: Africa Private Healthcare Expenditure, 2015-2019, $ Billion

Table 163: Africa Healthcare Services Market Size, 2015-2020, $ Billion

Table 164: Africa Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million

Table 165: Africa Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 166: Africa Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 167: Africa Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 168:AfricaGastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 169:AfricaGastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 170: Global Gastric Cancer Drugs Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)

Table 171: F. Hoffmann-La Roche Ltd – Financial Overview, 2016 - 2020, $ Billion

Table 172: Eli Lilly And Company – Financial Overview, 2016 - 2020, $ Billion

Table 173: Otsuka Pharmaceutical – Financial Overview, 2015 - 2019, $ Million

Table 174: Jiangsu HengRui Medicine – Financial Overview, 2016 - 2020, $ Billion

Table 175: Biocon – Financial Overview, 2016 - 2020, $ Billion

Table 176: Global Gastric Cancer Drugs Market, Pipeline Analysis

Table 177: Global Gastric Cancer Drugs Market Size Gain ($ Million), 2020 – 2025, By Country

Table 178: Global Gastric Cancer Drugs Market Size Gain ($ Million), Segmentation By Type, 2020 – 2025

Table 179: Global Gastric Cancer Drugs Market Size Gain ($ Million), Segmentation By End User, 2020 – 2025

Table 180: Global Gastric Cancer Drugs Market Size Gain ($ Million), Segmentation By End User, 2020 – 2025

List Of Figures

Figure 1: Global Gastric Cancer Drugs Market Segmentation By Type

Figure 2: Global Gastric Cancer Drugs Market Segmentation By End-User

Figure 3: Global Gastric Cancer Drugs Market Segmentation By Route Of Administration

Figure 4: Global Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million

Figure 5: Global Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 6: Global Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 7: Global Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 8: Global Gastric Cancer Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 9: Global Gastric Cancer Drugs Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 10: Global Gastric Cancer Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 11: Asia-Pacific Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million

Figure 12: Asia-Pacific Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 13: Asia-Pacific Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 14: Asia-Pacific Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 15: China Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million

Figure 16: China Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 17: China Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 18: China Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 19: India Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million

Figure 20: India Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 21: India Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 22: India Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 23: Japan Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million

Figure 24: Japan Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 25: Japan Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 26: Japan Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 27: Australia Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million

Figure 28: Australia Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 29: Australia Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 30: Australia Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 31: Indonesia Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million

Figure 32: Indonesia Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 33: Indonesia Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 34: Indonesia Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 35: South Korea Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million

Figure 36: South Korea Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 37: South Korea Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 38: South Korea Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 39: Western Europe Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million

Figure 40: Western Europe Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 41: Western Europe Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 42: Western Europe Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 43: UK Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million

Figure 44: UK Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 45: UK Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 46: UK Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 47: Germany Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million

Figure 48: Germany Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 49: Germany Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 50: Germany Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 51: France Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million

Figure 52: France Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 53: France Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 54: France Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 55: Eastern Europe Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million

Figure 56: Eastern Europe Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 57: Eastern Europe Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 58: Eastern Europe Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 59: Russia Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million

Figure 60: Russia Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 61: Russia Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 62: Russia Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 63: North America Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million

Figure 64: North America Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 65: North America Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 66: North America Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 67: USA Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million

Figure 68: USA Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 69: USA Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 70: USA Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 71: South America Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million

Figure 72: South America Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 73: South America Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 74: South America Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 75: Brazil Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million

Figure 76: Brazil Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 77: Brazil Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 78: Brazil Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 79: Middle East Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million

Figure 80: Middle East Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 81: Middle East Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 82: Middle East Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure83: Africa Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million

Figure 84: Africa Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 85: Africa Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 86: Africa Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 87: Global Gastric Cancer Drugs Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)

Figure 88: F. Hoffmann-La Roche Ltd – Financial Overview, 2016 – 2020, $ Billion

Figure 89: Eli Lilly And Company – Financial Overview 2016 – 2020, $ Billion

Figure 90: Otsuka Pharmaceutical – Financial Overview, 2015 – 2019, $ Million

Figure 91: Jiangsu HengRui Medicine – Financial Overview, 2016 – 2020, $ Billion

Figure 92: Biocon – Financial Overview, 2016 – 2020, $ Billion

Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company

Global Gene Therapy Market 2022 – Market Opportunities And Strategies

The Microbiome Market Share, Market Size, And Growth Rate 2022

Latest TNF Alpha Inhibitors Market Growth Study 2022-2026 By The Business Research Company

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the dermatitis market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the insulin drugs market research report 2022 with industry size, share, segments and market growth

CAR-T Therapy Market 2021 - By Target Antigen (CD19, CD22, BCMA), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma), And By Region, Opportunities And Strategies – Global Forecast To 2030

View Report

Central Nervous System Drugs Market 2021 - By Type (Multiple Sclerosis (MS), Anti-Psychotic, Analgesics, Anti-Parkinson Drugs, Anesthetics, Anti-Epileptics, Anti-Depressants, Other CNS Drugs), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Administration (Oral, Intravenous, Intranasal/ Inhalation), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Over-The-Counter Drugs, Prescription-Based Drugs), And By Region, Opportunities And Strategies – Global Forecast To 2030

View Report

Oncology Drugs Market 2023 – By Type (Lung Cancer, Pancreatic Cancer, Breast Cancer, Prostate Cancer, Ovarian Cancer, Colorectal Cancer, Gastric Cancer, Kidney Cancer, Brain Tumor, Thyroid Cancer, Skin Cancer, Bladder Cancer, Cervical Cancer, Blood Cancer, Other Oncology Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/Drug Stores, Other Distribution Channels), By Route Of Administration (Oral, Parental, Other Route Of Administration), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs), And By Region, Opportunities And Strategies – Global Forecast To 2032

View Report

Dry Eye Medication Market 2021 - By Prescription Type (OTC Drugs, Prescription Drugs) By Drug Variation (Branded, Generic) By Type Of Product (Aqueous, Evaporative, Aqueous And Evaporative) By Distribution Channel (Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, Online Pharmacies) By Delivery System (Liquid, Gel, Ointment) And By Region, Opportunities And Strategies – Global Forecast To 2030

View Report

Biosimilars Global Market Report 2024 – By Type (Monoclonal Antibodies, Insulin, Erythropoietin, Granulocyte-Colony Stimulating Factor, Other Hormones, Others), By Product (Recombinant Non-glycosylated Proteins, Recombinant Glycosylated Proteins), By Application (Oncology, Chronic And Autoimmune Diseases, Growth Hormone Deficiency, Infectious Diseases, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Digestive Enzymes Global Market Report 2024 – By Enzyme Type (Carbohydrates, Protease, Lipase, Other Enzyme Types), By Origin (Animal, Fungi, Microbial, Plant), By Application (Indigestion, Chronic Pancreatitis, Irritable Bowel Syndrome, Other Applications), By Distribution Channel (Retail Stores, Online Stores) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Corticosteroids Global Market Report 2024 – By Product (Glucocorticoids, Mineralocorticoids), By Application (Skin Allergies, Rheumatology Indications, Endocrinology, Acute Respiratory Diseases, Other Applications), By End User (Hospitals, Clinics, Research Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Interferons Global Market Report 2024 – By Type (Interferon Alpha, Interferon Beta, Interferon Gamma), By Application (Hepatitis B, Hepatitis C, Melanoma, Leukemia, Multiple Sclerosis, Renal Cell Carcinoma), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Frequently Asked Questions

What is the definition of the gastric cancer drugs global market?

How will the gastric cancer drugs global market drivers and restraints affect gastric cancer drugs global market dynamics? What forces will shape the gastric cancer drugs global industry going forward?

The gastric cancer drugs market growth is aided by increase in gastric cancer incidence rate. However, some gastric cancer drugs market restraints include high costs of drugs request a sample here

What is the forecast market size of the gastric cancer drugs global market?

The gastric cancer drugs market forecast is expected to reach $4,832.0 million in 2030 at a compound annual growth rate of 4.3%. request a sample here

How is the gastric cancer drugs global market segmented?

The global gastric cancer drugs market is segmented -
1) By Type – Imatnib, Trastuzumab, Others
2) By End-User – Hospitals, Clinics, Cancer Specialty Centers
3) By Route of Administration – Oral, Parental request a sample here

Which region has largest share, and what is the market size and growth by geography according to the gastric cancer drugs global global market report?

For this and further detailed insights on the market, request a sample here. request a sample here.

Who are the key players of the global gastric cancer drugs global market?

Top competitors in the gastric cancer drugs market include F. Hoffmann-La Roche, Eli Lilly and Company, Otsuka Pharmaceutical, Jiangsu HengRui Medicine, Biocon request a sample here.

What are the key trends in the global gastric cancer drugs global market?

Major trends influencing the gastric cancer drugs market include strategic collaborations and agreements request a sample here.

What are the major opportunities in the gastric cancer drugs global market and the approaches companies can take to take advantage of them?

For this and further detailed insights on the market, request a sample here. request a sample here.

How does the gastric cancer drugs global market relate to the overall economy and other similar markets?

request a sample here.